Delivery Order SPE2DX22D0010-SPE2D826FAC64
- Not listed
- AmerisourceBergen Drug Corp received a competitively awarded delivery order from the Defense Logistics Agency's Medical Supply Chain for OxyContin 20mg tablets with a ceiling value of $5,702.74. The contract, awarded on September 28, 2025, with an ultimate completion date of September 29, 2025, represents a firm fixed-price transaction with no set-aside designation. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,007.92 on September 12, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). The contract is competitively awarded with no set-aside designation and features firm fixed pricing, with an ultimate completion date of September 15, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain, a division of the...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 7, 2025, for the supply of OxyContin tablets (20mg) with a ceiling value of $5,702.74. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The award was competitively awarded...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of OxyContin tablets (20mg) with a ceiling value of $2,269.50. This firm fixed-price delivery order, with an ultimate completion date of September 19, 2025, represents a competitive award with no set-aside designation. The contract is executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, leveraging the company's extensive...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of OxyContin ER 80 mg tablets (100-count units) valued at $5,025.57. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance is scheduled for completion by August 12, 2025, with the product to be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office....
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,862.76 by the Defense Logistics Agency's Medical Supply Chain for the supply of OxyContin Tabs 20mg. The contract, awarded on June 1, 2025, with an ultimate completion date of June 2, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for OxyContin ER 30 mg tablets (100-count units) with a ceiling value of $1,717.40. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 28, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of OxyContin tablets (20mg) with a ceiling value of $3,304.45. This firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain has awarded AmerisourceBergen Drug Corp a delivery order valued at $5,702.74 for OxyContin tablets (20mg) under a firm fixed-price contract. The award, made on August 31, 2025, with an ultimate completion date of September 2, 2025, represents a competitive, non-set-aside procurement for pharmaceutical supply to support military healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 8, 2025, for the supply of OxyContin tablets (20 mg) with a ceiling value of $3,184.28. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set to conclude on June 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAC64Delivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,072.23 for OxyContin tablets (20mg) by the Department of Defense Medical Supply Chain, with an award date of October 5, 2025, and ultimate completion by October 6, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of pharmaceutical products and medical supplies supporting military and veteran healthcare systems. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 10/5/25 |